James T. Parsons

CIK: 0001759855

Transaction Breakdown

Open Market Buys (P)1 (14.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (14.3%)

Derivative conversions

Awards (A)5 (71.4%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

DMAC

DiaMedica Therapeutics Inc.

Director

ONCY

ONCOLYTICS BIOTECH INC

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

DMAC
DiaMedica Therapeutics Inc.
Jun 1, 2026
Award(A)
Stock Option (right to buy)
Direct
51.2K shares-
ONCY
ONCOLYTICS BIOTECH INC
Jun 1, 2026
Award(A)
Stock Option
Direct
30K shares-
ONCY
ONCOLYTICS BIOTECH INC
Mar 11, 2026
Purchase(P)
Direct
10K shares at avg. $1.03$10K
DMAC
DiaMedica Therapeutics Inc.
Jan 2, 2026
Award(A)
Direct
10.1K shares at avg. $8.42$85K
DMAC
DiaMedica Therapeutics Inc.
Nov 21, 2025
Exercise(M)
Direct
12K shares at avg. $2.20$26K
DMAC
DiaMedica Therapeutics Inc.
Jun 1, 2025
Award(A)
Stock Option (right to buy)
Direct
40.7K shares-
DMAC
DiaMedica Therapeutics Inc.
Jan 2, 2025
Award(A)
Direct
15.9K shares at avg. $5.34$85K

		Type	Shares	Price		Ownership
Jun 1, 2026	DMAC DiaMedica Therapeutics Inc.	Award(A) Stock Option (right to buy)	51,189	-	-	Direct
Jun 1, 2026	ONCY ONCOLYTICS BIOTECH INC	Award(A) Stock Option	30,000	-	-	Direct
Mar 11, 2026	ONCY ONCOLYTICS BIOTECH INC	Purchase(P)	10,000	$1.03	$10,300	Direct
Jan 2, 2026	DMAC DiaMedica Therapeutics Inc.	Award(A)	10,095	$8.42	$85,000	Direct
Nov 21, 2025	DMAC DiaMedica Therapeutics Inc.	Exercise(M)	12,000	$2.20	$26,400	Direct
Jun 1, 2025	DMAC DiaMedica Therapeutics Inc.	Award(A) Stock Option (right to buy)	40,739	-	-	Direct
Jan 2, 2025	DMAC DiaMedica Therapeutics Inc.	Award(A)	15,917	$5.34	$84,997	Direct

1-7 of 7 transactions

About Parsons James T.

Parsons James T. (SEC CIK 0001759855) files insider reports with the SEC as Director of DiaMedica Therapeutics Inc. (DMAC) and Director of ONCOLYTICS BIOTECH INC (ONCY).

Signal8 holds 8 ownership filings by Parsons James T. (1 Form 3, 7 Form 4), filed between Jan 3, 2025 and Jun 3, 2026. Those filings report 7 transactions, from Jan 2, 2025 to Jun 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Parsons James T.'s filings is in SAN DIEGO, CA.

Recent filings by Parsons James T.

Jun 1, 2026: Grant or award of DMAC derivative securities (Form 4, code A).
Jun 1, 2026: Grant or award of ONCY derivative securities (Form 4, code A).
Mar 11, 2026: Open-market purchase of ONCY shares (Form 4, code P).
Jan 2, 2026: Grant or award of DMAC shares (Form 4, code A).
Nov 21, 2025: Option exercise of DMAC shares (Form 4, code M).

Other insiders filing for DiaMedica Therapeutics Inc. (DMAC)

Pauls Dietrich John, President & CEO
Giuffre Randall Michael, Director
Kuntz Richard, Director
O'Connor Daniel J., Director
Lewis Tanya, Director
Semba Charles Pauling, Director

How to read Form 4 transaction codes